Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Gs-9669
1. Gs-9669
2. Radalbuvir [inn]
3. 273k4v0spc
4. 2-thiophenecarboxylic Acid, 5-(3,3-dimethyl-1-butyn-1-yl)-3-((cis-4-hydroxy-4-((((3s)-tetrahydro-3-furanyl)oxy)methyl)cyclohexyl)(((1r)-4-methyl-3-cyclohexen-1-yl)carbonyl)amino)-
5. 1314795-11-3
6. Unii-273k4v0spc
7. Radalbuvir [who-dd]
8. Chembl3121539
9. Schembl12444696
10. Schembl15252929
11. Schembl15252930
12. Schembl19607380
13. Dtxsid401028100
14. Db12065
15. Hy-16750
16. Cs-0012349
17. Q21098892
18. 5-(3,3-dimethylbut-1-ynyl)-3-[[4-hydroxy-4-[[(3s)-tetrahydrofuran-3-yl]oxymethyl]cyclohexyl]-[(1r)-4-methylcyclohex-3-ene-1-carbonyl]amino]thiophene-2-carboxylic Acid
| Molecular Weight | 543.7 g/mol |
|---|---|
| Molecular Formula | C30H41NO6S |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 9 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 125 |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 966 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Radalbuvir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Radalbuvir, including repackagers and relabelers. The FDA regulates Radalbuvir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Radalbuvir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Radalbuvir supplier is an individual or a company that provides Radalbuvir active pharmaceutical ingredient (API) or Radalbuvir finished formulations upon request. The Radalbuvir suppliers may include Radalbuvir API manufacturers, exporters, distributors and traders.
Radalbuvir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Radalbuvir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Radalbuvir GMP manufacturer or Radalbuvir GMP API supplier for your needs.
A Radalbuvir CoA (Certificate of Analysis) is a formal document that attests to Radalbuvir's compliance with Radalbuvir specifications and serves as a tool for batch-level quality control.
Radalbuvir CoA mostly includes findings from lab analyses of a specific batch. For each Radalbuvir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Radalbuvir may be tested according to a variety of international standards, such as European Pharmacopoeia (Radalbuvir EP), Radalbuvir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Radalbuvir USP).
LOOKING FOR A SUPPLIER?
